Á lódáil...
Cardiotoxicity Monitoring in Patients Treated with Tyrosine Kinase Inhibitors
Tyrosine kinase inhibitors (TKIs) can cause cardiotoxicity, and some suggest routine monitoring of cardiac function during TKI use. We describe two cases of TKI‐induced heart failure (HF) that suggest the utility of monitoring with laboratory tests is questionable. One patient developed HF 5 days af...
Na minha lista:
| Foilsithe in: | Oncologist |
|---|---|
| Príomhúdar: | |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
John Wiley & Sons, Inc.
2019
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6656470/ https://ncbi.nlm.nih.gov/pubmed/30971480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0891 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|